Curium restores US supply of thallium 201 for nuclear cardiology imaging
Curium has resumed U.S. production and distribution of Thallous Chloride TI 201 Injection, restoring availability of the radiopharmaceutical after manufacturing ended in 2022. The Boston-based company said the product, commonly known as thallium 201, is …